SC
CRL icon

Syon Capital’s Charles River Laboratories CRL Stock Holding History

Syon Capital’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$804K Buy
3,547
+83
+2% +$14.8K 0.04% 430
2026
Q1 		$598K Sell
3,464
-367
-10% -$68K 0.03% 486
2025
Q4 		$764K Sell
3,831
-579
-13% -$105K 0.04% 394
2025
Q3 		$690K Buy
4,410
+2,252
+104% +$358K 0.04% 373
2025
Q2 		$327K Buy
2,158
+470
+28% +$62.7K 0.02% 514
2025
Q1 		$254K Buy
+1,688
New +$283K 0.02% 473

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Syon Capital's CRL Position: Q2 2026 in Review

Syon Capital increased its Charles River Laboratories (CRL) stake by 2.4% in Q2 2026, buying an estimated $14.8K and bringing the position to 3,547 shares worth $804K. The position accounts for 0.04% of the portfolio, ranked #430.

Syon Capital first reported a position in CRL in Q1 2025 and has held it in 6 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Syon Capital held 3,547 shares of Charles River Laboratories worth $804K as of Q2 2026.
  • Syon Capital bought 83 Charles River Laboratories shares in Q2 2026, an estimated $14.8K.
  • Charles River Laboratories made up 0.04% of Syon Capital's portfolio in Q2 2026, its #430 holding.
  • Syon Capital first reported a position in Charles River Laboratories in Q1 2025 and has held it in 6 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.